GlassScriptPhysician profile
Caroline Lawrence
NPI 1659166395
$744.42
in general payments reported to CMS, 2019-2025
15 companies · $744 in 2025
The $744 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $105.54 | 2025 | Recorlev, Gvoke Hypopen |
| Dexcom, INC. | $83.57 | 2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $81.29 | 2025 | Freestyle Libre |
| Beta Bionics, INC. | $78.11 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.16 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $65.93 | 2025 | |
| Ascendis Pharma Endocrinology INC | $47.44 | 2025 | Yorvipath |
| Sequel Med Tech, LLC | $42.10 | 2025 | Twiist |
| Novo Nordisk INC | $40.69 | 2025 | Wegovy |
| Avvisto Therapeutics, LLC | $34.68 | 2025 | Cycloset |
| Tandem Diabetes Care, INC. | $27.39 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Mannkind Corporation | $16.95 | 2025 | |
| Lilly USA, LLC | $15.87 | 2025 | Zepbound, Mounjaro |
| Ibsa Pharma INC. | $14.88 | 2025 | Tirosint, Flector, Licart |
| Esperion Therapeutics, INC. | $13.82 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.